Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Randomised Phase II Trial of Osimertinib With or Without SRS for EGFR Mutated NSCLC With Brain Metastases

Trans Tasman Radiation Oncology Group · 2019
ClinicalTrials.gov · Datasets · License: Public Domain · 2019
Open Source ↗
metastatic non small cell lung cancer, non small cell lung cancer (nsclc), egfr mutation, osimertinib, stereotactic radiosurgery, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 884935
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.